SCHEMBL6208751

SCHEMBL6208751

O=[N+]([O-])c1cc(CCl)ccc1Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.49
ALDH1A1 P00352 6/20 0.46
CYP2D6 P10635 1/20 0.46
MAPT P10636 4/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPK1 P28482 2/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
ABL1 P00519 3/20 0.39
BCR P11274 3/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.38
CTSB P07858 1/20 0.38
XDH P47989 1/20 0.37
CYP19A1 P11511 1/20 0.36
PDE7A Q13946 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9138875 0.85 ALDH1A1 (0.49) TSHRALDH1A1CYP2D6MAPTKDM4E
SCHEMBL672403 0.85 ALDH1A1 (0.49) ALDH1A1CYP2D6MAPTKDM4EMAPK1
SCHEMBL29519283 0.85 ALDH1A1 (0.49) ALDH1A1CYP2D6MAPTKDM4EMAPK1
SCHEMBL3073523 0.83 ALDH1A1 (0.47) ALDH1A1CYP2D6MAPTKDM4EMAPK1
SCHEMBL30385788 0.83 ALDH1A1 (0.47) ALDH1A1CYP2D6MAPTKDM4EMAPK1
SCHEMBL279049 0.81 ALDH1A1 (0.50) TSHRALDH1A1CYP2D6MAPTKDM4E
SCHEMBL15286114 0.81 ALDH1A1 (0.46) ALDH1A1CYP2D6MAPTKDM4EMAPK1
SCHEMBL278730 0.81 ALDH1A1 (0.50) ALDH1A1CYP2D6MAPTKDM4EMAPK1
SCHEMBL12509542 0.81 ALDH1A1 (0.43) ALDH1A1CYP2D6MAPTKDM4EMAPK1
SCHEMBL3903310 0.80 ALDH1A1 (0.45) ALDH1A1CYP2D6MAPTKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549632-A4 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS DIMENSIONAL PHARM INC (US) 2005-11-09 EP disclosed
EP-1549632-A1 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2005-07-06 EP disclosed
WO-2003099805-A1 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-12-04 WO disclosed